サンプル依頼リスト カート
  • English
  • Korean
表紙：動物用医薬品におけるモノクローナル抗体の市場規模、シェア、動向分析レポート：用途別、動物種別、エンドユーザー別、地域別、セグメント別予測、2023年～2030年
市場調査レポート
商品コード
1321473

動物用医薬品におけるモノクローナル抗体の市場規模、シェア、動向分析レポート：用途別、動物種別、エンドユーザー別、地域別、セグメント別予測、2023年～2030年

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
動物用医薬品におけるモノクローナル抗体の市場規模、シェア、動向分析レポート：用途別、動物種別、エンドユーザー別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年07月10日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用医薬品におけるモノクローナル抗体市場の成長と動向

Grand View Research, Inc.の最新レポートによると、動物用医薬品におけるモノクローナル抗体の世界市場規模は、2023年から2030年にかけてCAGR 17.1%で拡大し、2030年には24億2,000万米ドルに達すると予測されています。

ペット人口の増加とペット支出の増加が相まって、市場成長を後押しすると予想されています。さらに、犬アトピー性皮膚炎の有病率の増加が、予測期間中の市場成長を促進する可能性が高いです。

COVID-19パンデミックによる混乱にもかかわらず、動物用医薬品業界は2019年から2020年にかけて8%の安定した成長が見られました。経済不況は、他の市場に比べて動物用医薬品業界では比較的影響が少なかっています。パンデミックは、動物病院と獣医師のビジネスモデルにいくつかの変化をもたらしました。従来の動物病院は、生物製剤や医薬品のような利益率の高い製品の販売から最も多くの収益を上げると予想されます。

特に犬におけるがんの増加は、市場に成長基盤を提供すると予想されます。米国獣医師会（AVMA）によると、犬の4頭に1頭は、生涯のある時点で新形成の兆候を示すと予想されています。新形成は犬によく見られるがんの一種です。疼痛管理は、犬の新形成の治療において最も重要な側面のひとつです。これはモノクローナル抗体による治療も可能です。

市場は競争が激しく、複数の大手企業が参入しています。市場に巨大な機会が出現したことで、市場の様々なプレーヤーがリーディング・プレーヤーとして台頭するために投資を行っています。例えば、2021年10月、Zoetis社は動物用医薬品におけるモノクローナル抗体（mAbs）の生産能力を向上させるため、アイルランドに新たな開発・製造ユニットを取得しました。

これにより、動物用治療バイオ医薬品のポートフォリオが強化されると予想されます。さらに2021年8月、エランコはキンドレッド・バイオサイエンシズを約4億4,400万米ドルで買収しました。これにより、エランコは皮膚科市場への参入を支援し、製品パイプラインを補完し、生物製剤とモノクローナル抗体の研究開発能力を強化しました。

さらに2023年5月、エランコはモノクローナル抗体を用いた致死的な犬パルボウイルス疾患の画期的な治療法を発表しました。この一回の静脈内投与で、ワクチン接種の有無にかかわらず、病気の犬や子犬のパルボウイルスによって引き起こされる徴候を治療します。

動物用医薬品におけるモノクローナル抗体市場レポートハイライト

  • 動物の種類別では、ペットとしての犬の採用が増加していること、犬の病気治療をターゲットとした研究開発が増加していることから、犬セグメントが2022年に圧倒的な収益シェアを占めました。
  • 用途別では、犬のアトピー性皮膚炎の有病率の増加により、皮膚科分野が2022年に50%以上の最大市場シェアを占めました。
  • 動物病院セグメントは、動物病院における高度な治療施設の利用可能性により、2022年のエンドユーザーで圧倒的な市場シェアを占めました。
  • 北米は、同地域の主要市場プレイヤーの存在により、2022年には約40%の最大市場シェアを占めました。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報またはデータ分析
  • 一般的な調査手法
  • 調査範囲と前提条件
  • 市場の形成と検証
  • モデル詳細
  • 二次情報のリスト

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題の分析
  • 業界分析
    • ポーター
    • PESTEL
  • 規制の枠組み
  • 製品パイプライン分析
  • COVID-19の影響分析

第4章 動物用医薬品におけるモノクローナル抗体市場：動物タイプの推定・動向分析

  • セグメントダッシュボード
  • 動物用医薬品におけるモノクローナル抗体市場：動物タイプの変動分析、100万米ドル、2022年および2030年
  • 犬
  • その他

第5章 動物用医薬品におけるモノクローナル抗体市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 動物用医薬品におけるモノクローナル抗体市場：用途変動分析、100万米ドル、2022年および2030年
  • 皮膚科
  • 痛み
  • その他

第6章 動物用医薬品におけるモノクローナル抗体市場：エンドユーザーの推定・動向分析

  • 動物用医薬品におけるモノクローナル抗体市場：エンドユーザーの変動分析、100万米ドル、2022年および2030年
  • 動物病院
  • その他

第7章 動物用医薬品におけるモノクローナル抗体市場：地域推定・動向分析

  • 動物用医薬品におけるモノクローナル抗体市場：地域変動分析、2022年および2030年
  • 北米
    • SWOT分析
    • 北米の動物用医薬品におけるモノクローナル抗体市場推計・予測、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州の動物用医薬品におけるモノクローナル抗体市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋地域の動物用医薬品におけるモノクローナル抗体市場推計・予測、2018～2030年
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの動物用医薬品におけるモノクローナル抗体市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • SWOT分析
    • 中東およびアフリカの動物用医薬品におけるモノクローナル抗体市場推計・予測、2018～2030年
    • 南アフリカ
    • サウジアラビア

第8章 競合情勢

  • 市場参加の分類
  • 主要な企業プロファイル
    • Zoetis
    • Merck &Co, Inc.
    • Elanco
    • Boehringer Ingelheim GmbH
    • Indian Immunologicals Ltd
    • Virbac
  • List of Other Players（inclusive of companies with pipeline products）
図表

List of Tables

  • Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Region, 2018 - 2030 (USD Million)
  • Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 4 North America Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 5 North America Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 6 US Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 7 US Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 8 US Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 9 Canada Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 10 Canada Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 11 Canada Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 13 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 14 Europe Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 15 Europe Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 16 Germany Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 17 Germany Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 18 Germany Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 19 UK Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 22 Spain Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 23 Spain Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 24 Spain Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 25 Italy Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 26 Italy Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 27 Italy Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 29 France Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 30 France Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 33 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 34 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 35 Japan Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 36 Japan Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 37 Japan Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 38 China Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 39 China Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 40 China Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 41 India Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 42 India Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 43 India Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 44 Australia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 45 Australia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 46 Australia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 47 South Korea Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 48 South Korea Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 49 South Korea Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 51 LATAM Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 52 LATAM Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 53 LATAM Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 54 Brazil Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 55 Brazil Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 56 Brazil Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 57 Mexico Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 58 Mexico Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 59 Mexico Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 60 Argentina Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 61 Argentina Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 62 Argentina Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 64 MEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 65 MEA Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 66 MEA Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 67 South Africa Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 68 South Africa Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 69 South Africa Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 70 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 71 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 72 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 73 Participant's overview
  • Table 74 Financial performance
  • Table 75 Product Benchmarking
  • Table 76 Key companies undergoing strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Ansoff's matrix analysis
  • Fig. 14 Heat map analysis
  • Fig. 15 Market penetration vs growth prospect mapping
  • Fig. 16 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
  • Fig. 17 Strategy mapping
  • Fig. 18 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2022
  • Fig. 19 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
  • Fig. 20 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Monoclonal Antibodies in Veterinary Health Market application outlook: 2022
  • Fig. 23 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
  • Fig. 24 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 25 Pain market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2022
  • Fig. 28 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
  • Fig. 29 Veterinary Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace: 2022
  • Fig. 32 Regional outlook, 2018 & 2030
  • Fig. 33 North America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participant categorization
目次
Product Code: GVR-4-68039-973-5

Monoclonal Antibodies In Veterinary Health Market Growth & Trends

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights

  • Based on animal type, the dog segment held the dominant revenue share in 2022 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 50% in 2022, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2022, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 40% in 2022, owing to the presence of major market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End-User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. SWOT Analysis
    • 7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participation Categorization
  • 8.2. Key Company Profiles
    • 8.2.1 Zoetis
    • 8.2.2 Merck & Co, Inc.
    • 8.2.3 Elanco
    • 8.2.4 Boehringer Ingelheim GmbH
    • 8.2.5 Indian Immunologicals Ltd
    • 8.2.6 Virbac
      • 8.2.6.1. Participant's Overview
      • 8.2.6.2. Product Benchmarking
      • 8.2.6.3. Financial Performance
      • 8.2.6.4. Strategy Mapping
  • 8.3. List of Other Players (inclusive of companies with pipeline products)